115 Publications (Page 3 of 5)
2011
The endocannabinoid system and cancer: therapeutic implication.
Guindon, Josée and Hohmann, Andrea G
British journal of pharmacology, vol. 163, (no. 7), pp. 1447-63, 2011/Aug. | Journal Article
2010
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism
Clapper, Jason RClapper, Jason RMoreno-sanz, GuillermoMoreno-Sanz, GuillermoRusso, RobertoRusso, RobertoGuijarro, AnaGuijarro, AnaVacondio, FedericaVacondio, FedericaDuranti, AndreaDuranti, AndreaTontini, AndreaTontini, AndreaSanchini, SilvanoSanchini, SilvanoSciolino, NataleSciolino, Natale RSpradley, Jessica MSpradley, Jessica MHohmann, Andrea GHohmann, Andrea GCalignano, AntonioCalignano, AntonioMor, MarcoMor, MarcoTarzia, GiorgioTarzia, GiorgioPiomelli, Daniele and Piomelli, Daniele
Nature Neuroscience, vol. 13, (no. 10), pp. 1265-1270, 2010. | Journal Article
 
Antinociceptive effects of racemic AM1241 and its chirally synthesized enantiomers: lack of dependence upon opioid receptor activation.
Rahn, Elizabeth JZvonok, Alexander MMakriyannis, Alexandros and Hohmann, Andrea G
The AAPS journal, vol. 12, (no. 2), pp. 147-57, 2010/Jun. | Journal Article
 
A role for 2-arachidonoylglycerol and endocannabinoid signaling in the locomotor response to novelty induced by olfactory bulbectomy.
Eisenstein, SarahClapper, Jason RHolmes, Philip VPiomelli, Daniele and Hohmann, Andrea G
Pharmacological research : the official journal of the Italian Pharmacological Society, vol. 61, (no. 5), pp. 419-29, 2010/May. | Journal Article
 
Inhibitors of monoacylglycerol lipase, fatty-acid amide hydrolase and endocannabinoid transport differentially suppress capsaicin-induced behavioral sensitization through peripheral endocannabinoid mechanisms.
Spradley, Jessica MGuindon, Josée and Hohmann, Andrea G
Pharmacological research : the official journal of the Italian Pharmacological Society, vol. 62, (no. 3), pp. 249-58, 2010/Sep. | Journal Article
 
Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult rats
Sciolino, NataleBortolato, M.Eisenstein, SarahFu, J.Oveisi, F.Hohmann, Andrea G and Piomelli, Daniele
Neuroscience, vol. 168, (no. 2), pp. 371-386, 2010. | Journal Article
2009
Cannabinoids as pharmacotherapies for neuropathic pain: from the bench to the bedside.
Rahn, Elizabeth J and Hohmann, Andrea G
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, vol. 6, (no. 4), pp. 713-37, 2009/Oct. | Journal Article
 
Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation.
Eisenstein, SarahHolmes, Philip V and Hohmann, Andrea G
Synapse (New York, N.Y.), vol. 63, (no. 11), pp. 941-50, 2009/Nov. | Journal Article
 
Molecular architecture of endocannabinoid signaling at nociceptive synapses mediating analgesia.
Nyilas, RitaGregg, Laura CMackie, Kenneth PWatanabe, MasahikoZimmer, AndreasHohmann, Andrea G and Katona, István
The European journal of neuroscience, vol. 29, (no. 10), pp. 1964-78, 2009/May. | Journal Article
 
Targeting CB2 receptors and the endocannabinoid system for the treatment of pain.
Anand, PraveenWhiteside, GarthFowler, Christopher and Hohmann, Andrea G
Brain research reviews, vol. 60, (no. 1), pp. 255-66, 2009/Apr. | Journal Article
 
The endocannabinoid system and pain.
Guindon, Josée and Hohmann, Andrea G
CNS & neurological disorders drug targets, vol. 8, (no. 6), pp. 403-21, 2009/Dec. | Journal Article
2008
An endocannabinoid signaling system modulates anxiety-like behavior in male Syrian hamsters
Moise, Anna MEisenstein, SarahAstarita, GiuseppePiomelli, Daniele and Hohmann, Andrea G
Psychopharmacology, vol. 200, (no. 3), pp. 333-346, 2008. | Journal Article
 
A physiological role for endocannabinoid-derived products of cyclooxygenase-2-mediated oxidative metabolism
Guindon, J and Hohmann, Andrea G
British Journal of Pharmacology, vol. 153, (no. 7), pp. 1341-3, Apr 2008. | Journal Article
 
Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain.
Guindon, J and Hohmann, Andrea G
British journal of pharmacology, vol. 153, (no. 2), pp. 319-34, 2008/Jan. | Journal Article
 
Cannabinoid CB@d2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain
Guindon, J. and Hohmann, Andrea G
British Journal of Pharmacology, vol. 153, (no. 2), pp. 319-334, 2008. | Journal Article
 
Cross-sensitization and cross-tolerance between exogenous cannabinoid antinociception and endocannabinoid-mediated stress-induced analgesia.
Suplita, Richard LEisenstein, SarahNeely, Mark HMoise, Anna M and Hohmann, Andrea G
Neuropharmacology, vol. 54, (no. 1), pp. 161-71, 2008/Jan. | Journal Article
 
Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats.
Rahn, Elizabeth JZvonok, Alexander MThakur, Ganesh AKhanolkar, Atmaram DMakriyannis, Alexandros and Hohmann, Andrea G
The Journal of pharmacology and experimental therapeutics, vol. 327, (no. 2), pp. 584-91, 2008/Nov. | Journal Article
2007
Activation of cannabinoid CB1 and CB2 receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
Rahn, E JMakriyannis, A and Hohmann, Andrea G
British Journal of Pharmacology, vol. 152, (no. 5), pp. 765-77, Nov 2007. | Journal Article
 
Activation of cannabinoid CB sub(1) and CB sub(2) receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
Rahn, EJMakriyannis, A. and Hohmann, Andrea G
British Journal of Pharmacology, vol. 152, (no. 5), pp. 765-777, 2007. | Journal Article
 
Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis
Gutierrez, T.Farthing, J. NZvonok, A. MMakriyannis, A. and Hohmann, Andrea G
British Journal of Pharmacology, vol. 150, (no. 2), pp. 153-63, Jan 2007. | Journal Article
 
Activation of peripheral cannabinoid CB@d1 and CB@d2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis
Gutierrez, T.Farthing, JNZvonok, AMMakriyannis, A. and Hohmann, Andrea G
British Journal of Pharmacology, vol. 150, (no. 2), pp. 153-163, 2007. | Journal Article
 
Inhibitors of monoacylglycerol lipase as novel analgesics
Hohmann, Andrea G
British Journal of Pharmacology, vol. 150, (no. 6), pp. 673-5, Mar 2007. | Journal Article
2006
Endocannabinoid mechanisms of pain modulation.
Hohmann, Andrea G and Suplita, Richard L
The AAPS journal, vol. 8, (no. 4), pp. E693-708, 2006. | Journal Article
 
Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia
Suplita II, Richard LGutierrez, TanniaFegley, DarrenPiomelli, Daniele and Hohmann, Andrea G
Neuropharmacology, vol. 50, (no. 3), pp. 372-379, 2006. | Journal Article
 
Localization of cannabinoid CB1 receptor mRNA using ribonucleotide probes: methods for double- and single-label in situ hybridization
Hohmann, Andrea G
Methods in molecular medicine, vol. 123, pp. 89, 2006-00-00. | Journal Article